Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Dr. Datson s Labs Limited (NSE: DRDATSONS)

 
DRDATSONS Technical Analysis
1
As on N/A DRDATSONS SHARE Price closed @ N/A and we RECOMMEND N/A for LONG-TERM with Stoploss of N/A & N/A for SHORT-TERM with Stoploss of N/A we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

DRDATSONSSHARE Price

Open N/A Change Price %
High N/A 1 Day N/A N/A
Low N/A 1 Week N/A N/A
Close N/A 1 Month N/A N/A
Volume N/A 1 Year N/A N/A
52 Week High N/A | 52 Week Low N/A
 
NSE INDIA Most Active Stocks
IDEA 14.00 0.72%
YESBANK 26.15 0.77%
IRFC 158.05 5.19%
GMRINFRA 90.75 6.58%
HUDCO 228.10 12.34%
MAHABANK 67.65 3.68%
SAIL 168.55 2.18%
NHPC 92.55 1.65%
TATASTEEL 165.80 -1.13%
IDFCFIRSTB 84.80 1.68%
 
NSE INDIA Top Gainers Stocks
ROSSELLIND 468.35 20.00%
MGEL 23.25 19.85%
KIRLOSIND 5232.65 12.84%
HUDCO 228.10 12.34%
DPABHUSHAN 1133.45 10.42%
KECL 130.60 10.30%
EXCEL 0.55 10.00%
ACL 98.15 9.79%
ACL 98.15 9.79%
ACL 98.15 9.79%
 
NSE INDIA Top Losers Stocks
LTTS 4778.10 -7.81%
BAJFINANCE 6731.20 -7.73%
DBSTOCKBRO 50.90 -5.91%
COMPUSOFT 33.95 -5.56%
KSB 4674.75 -5.21%
KSB 4674.75 -5.21%
KSB 4674.75 -5.21%
KSB 4674.75 -5.21%
KSB 4674.75 -5.21%
KSB 4674.75 -5.21%
 
 
DRDATSONS
Daily Charts		 DRDATSONS
Intraday Charts		 Whats New @
Bazaartrend		 DRDATSONS
Free Analysis
 
DRDATSONS Important Levels Intraday
RESISTANCE
RESISTANCE
RESISTANCE
RESISTANCE
RESISTANCE
RESISTANCE
RESISTANCE
RESISTANCE
 
DRDATSONS Target April 2024
Share
4th UP Target
3rd UP Target
2nd UP Target
1st UP Target
1st DOWN Target
2nd DOWN Target
3rd DOWN Target
4th DOWN Target
 
DRDATSONS Weekly Target
4th UP Target
3rd UP Target
2nd UP Target
1st UP Target
1st DOWN Target
2nd DOWN Target
3rd DOWN Target
4th DOWN Target
 
DRDATSONS Target2024
4th UP Target
3rd UP Target
2nd UP Target
1st UP Target
1st DOWN Target
2nd DOWN Target
3rd DOWN Target
4th DOWN Target
 
Dr. Datson s Labs Limited ( NSE INDIA Symbol : DRDATSONS )
Sector : Pharmaceuticals And Other Stocks in Same Sector
 
DRDATSONS Synopsis Technicals View
50 Day EMA N/A (Short Term)
 N/A
100 Day EMA N/A (Mid Term) N/A
200 Day EMA N/A (Long Term) N/A
MACD (12 26 9) N/A N/A
RSI (14) N/A N/A
MFI (14) N/A N/A
CCI (20) N/A N/A
WILLIAM %R (14) N/A N/A
ADX (14) N/A N/A
PSAR N/A N/A
10 Day Avg Volume N/A
 
DRDATSONS Other Details
Segment EQ
Market Capital 0.00
Sector Pharmaceuticals
Industry
Offical website >
 
DRDATSONS Address
DRDATSONS
 N/A
 
DRDATSONS Latest News
 
Your Comments and Response on Dr. Datson s Labs Limited
 
DRDATSONS Business Profile
Dr Datson Labs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 105.61 crore.The company has reported a standalone sales of Rs 132.00 crore and a Net Profit of Rs 1.74 crore for the quarter ended Sep 2013. The company management includes Minhaj Khan - Ind. Non-Executive Director, Kannan K Vishwanath - Vice Chairman & Mng.Director, Prabhat K Goya - Whole Time Director, Shashikant B Shinde - Whole Time Director, Ullooppee S Badade - Non Executive Director, Giridhar G Pulleti - Non Executive Director, Balkrishna R Parab - Non Executive Director, N C Paul - Non Executive Director. It is listed on the BSE with a BSE Code of 533412 and the NSE with an NSE Code of DRDATSONS. Its Registered office is at Aanjaneya House, No.34, Postal Colony,,Chembur Mumbai,Maharashtra - 400071.Their Registrars are Link Intime India Pvt. Ltd.
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service